These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33549134)

  • 41. Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype.
    Ramachandran S; Fryer AA; Lovatt T; Lear J; Smith AG; Strange RC
    J Photochem Photobiol B; 2001 Oct; 63(1-3):1-7. PubMed ID: 11684446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of candidate genes for endometrial cancer in multi-omics: a Mendelian randomization analysis.
    Qin LH; Yang C; Song R; Chen PY; Jiang Z; Xu W; Zeng G; Liao JY; Long L
    Syst Biol Reprod Med; 2024 Dec; 70(1):299-311. PubMed ID: 39401154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
    Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
    Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Potential Biomarkers Associated with Basal Cell Carcinoma.
    Liu Y; Liu H; Bian Q
    Biomed Res Int; 2020; 2020():2073690. PubMed ID: 32382535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease.
    Meddens CA; Harakalova M; van den Dungen NA; Foroughi Asl H; Hijma HJ; Cuppen EP; Björkegren JL; Asselbergs FW; Nieuwenhuis EE; Mokry M
    Genome Biol; 2016 Nov; 17(1):247. PubMed ID: 27903283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
    Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
    Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Nan H; Xu M; Kraft P; Qureshi AA; Chen C; Guo Q; Hu FB; Curhan G; Amos CI; Wang LE; Lee JE; Wei Q; Hunter DJ; Han J
    Hum Mol Genet; 2011 Sep; 20(18):3718-24. PubMed ID: 21700618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Causal relationship between the gut microbiome and basal cell carcinoma, melanoma skin cancer, ease of skin tanning: evidence from three two-sample mendelian randomisation studies.
    Lou J; Cui S; Li J; Jin G; Fan Y; Huang N
    Front Immunol; 2024; 15():1279680. PubMed ID: 38304424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.
    Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ
    Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population.
    Yu H; Bi W; Liu C; Zhao Y; Zhang JF; Zhang D; Yue W
    J Psychiatr Res; 2014 Mar; 50():73-8. PubMed ID: 24365204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex-Stratified Polygenic Risk Score Identifies Individuals at Increased Risk of Basal Cell Carcinoma.
    Roberts MR; Sordillo JE; Kraft P; Asgari MM
    J Invest Dermatol; 2020 May; 140(5):971-975. PubMed ID: 31682843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
    Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
    Lin Y; Chahal HS; Wu W; Cho HG; Ransohoff KJ; Dai H; Tang JY; Sarin KY; Han J
    Int J Cancer; 2017 May; 140(9):2085-2091. PubMed ID: 28177523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.
    Ghafouri-Fard S; Abbasi A; Moslehi H; Faramarzi N; Taba Taba Vakili S; Mobasheri MB; Modarressi MH
    Br J Dermatol; 2010 Apr; 162(4):772-9. PubMed ID: 19886887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Causal relationship between genetically determined plasma metabolites and skin cancer: a two-sample Mendelian randomization study.
    Shao X; Yu R; Zhao H; Wu J; Wu Q; Shu P
    Arch Dermatol Res; 2024 May; 316(6):214. PubMed ID: 38787420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus.
    Soliai MM; Kato A; Helling BA; Stanhope CT; Norton JE; Naughton KA; Klinger AI; Thompson EE; Clay SM; Kim S; Celedón JC; Gern JE; Jackson DJ; Altman MC; Kern RC; Tan BK; Schleimer RP; Nicolae DL; Pinto JM; Ober C
    Genome Med; 2021 Oct; 13(1):157. PubMed ID: 34629083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment.
    Kaporis HG; Guttman-Yassky E; Lowes MA; Haider AS; Fuentes-Duculan J; Darabi K; Whynot-Ertelt J; Khatcherian A; Cardinale I; Novitskaya I; Krueger JG; Carucci JA
    J Invest Dermatol; 2007 Oct; 127(10):2391-8. PubMed ID: 17508019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal cell carcinoma: a dermatopathological and molecular biological update.
    Saldanha G; Fletcher A; Slater DN
    Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms in nucleotide excision repair genes and basal cell carcinoma of the skin.
    Pesz KA; Bieniek A; Gil J; Laczmanska I; Karpinski P; Makowska I; Trusewicz A; Sasiadek MM
    Int J Dermatol; 2014 Dec; 53(12):1474-7. PubMed ID: 25209577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.